LYEL
Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. annual/quarterly cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Lyell Immunopharma, Inc. cash on hand for the quarter ending December 31, 2025 were 60.2M, a 43.01% decrease year-over-year.
- Lyell Immunopharma, Inc. cash on hand for 2025 were 60.2M, a 43.01% decrease from 2024.
- Lyell Immunopharma, Inc. cash on hand for 2024 were 105.6M, a 27.50% decrease from 2023.
- Lyell Immunopharma, Inc. cash on hand for 2023 were 145.6M, a 17.88% increase from 2022.
- Lyell Immunopharma, Inc. cash on hand for 2022 were 123.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Lyell Immunopharma, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $60 |
| 2024 | $106 |
| 2023 | $146 |
| 2022 | $124 |
| 2021 | $294 |
| 2020 | $140 |
| Lyell Immunopharma, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $60 |
| 2024-12-31 | $106 |
| 2023-12-31 | $146 |
| 2022-12-31 | $124 |
| 2021-12-31 | $294 |
| 2020-12-31 | $140 |
Lyell Immunopharma, Inc. Cash on Hand — FAQ
Lyell Immunopharma, Inc. (LYEL) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's cash on hand history?
The chart and table above show Lyell Immunopharma, Inc.'s cash on hand by year and by quarter, including the growth rate.